Skip to main content

Table 5 Anti-malarial prescription practice in both study arms showing the frequency of use of different ACT and non-ACT drugs within each study group

From: The impact of rapid malaria diagnostic tests upon anti-malarial sales in community pharmacies in Gwagwalada, Nigeria

Antimalarial dispensed Intervention pharmacy (frequency and % antimalarials within study arm) n = 360 Control pharmacy (frequency and % antimalarials within study arm) n = 607
Artemether-Lumefantrine 180 337
(50.0%) (55.5%)
Artesunate-Amodiaquine 42 47
(11.7%) (7.7%)
Dihydroartemisinin-Piperaquine 30 33
(8.3%) (5.4%)
Artesunate-Sulfadoxine-Pyrimethamine 8 12
(2.2%) (2.0%)
ACT (total) 260 429
(72.2%) (70.6%)
Sulfadoxine-Pyrimethamine alone 39 75
(10.8%) (12.4%)
Artesunate alone 47 58
(13.1%) (9.6%)
Chloroquine alone 13 30
(3.6%) (4.9%)
Quinine alone 1 15
(0.3%) (2.5%)
Non-ACT (total) 100 178
(27.8%) (29.4%)